Broker Notes, Comments and Analysis

Broker notes, analysis and comments

Solid interims underpin FY18

Strix Group (LON:KETL) has announced a solid set of interim results providing a high level of confidence in the FY18 profit before tax forecast of £29.1m. Revenue increased 1.5% to..

2 contingent deals

On Tuesday 18 September 2018, XPS Pensions Group (”XPS”) announced two contingent deals: The proposed acquisition of Kier Pensions Unit (“KPU”) from Kier Group for total max consideration of £3.5m..

Growth set to gather pace

BigDish Plc (LON:DISH) is an early-stage revenue-generating technology company that has developed a yield management platform for the restaurant industry. BigDish’s proprietary platform allows restaurants to maximise their sales by..

Fully proven model rolls out

DP Poland (LON:DPP) has proved that the Domino’s formula works as well in Poland as it does elsewhere in the world; its mature stores are substantially profitable. With 60 stores..

A year of transition

H1/FY2018 represents another period of significant development at Flowtech Fluidpower Plc (LON:FLO). Organic growth of c.9% and the benefit of the Balu acquisition in March for £10.2m, alongside four during..

Maiden interims & rise in forecasts

This morning, JTC Group (LON:JTC) announces its interim results: Revenue rose 25.2% YoY to £35.3m (1H17: £28.2m); Underlying EBITDA rose 56.7% to £10.5m (1H17: £6.7m); Underlying EBITDA margin improved 6.3pp..

CEO Appointment & board changes

boohoo Group (LON:BOO) has this morning announced the appointment of John Lyttle as Group CEO (effective 15th March 2019) and the re-alignment of its wider executive board as it positions..

Annual Report & Accounts in line with pre-close statement

What’s new. City of London Investment Group (LON:CLIG) audited accounts released this morning are in line with its pre-close statement for the year to 30 June 2018, released on 17..

Strategy delivering growth above expectations

Tissue Regenix Group (LON:TRX) has a broad portfolio of regenerative medicine products for the biosurgery, orthopaedics, dental and cardiac markets. The company has two proprietary decellularisation technology platforms, for the..

Group synergies coming through

1pm Plc (LON:OPM) The FY’18 results delivered exactly what management promised. Loan origination was up 72%, revenue rose 78%, pre-tax profits increased 93%, while EPS grew 24%. The synergies from..

Interim results in line but operating environment remains difficult

Epwin Group like for like revenue was marginally ahead yoy at £142.4m, with notable growth seen in the extrusion, mouldings and distribution businesses, but declined on an absolute basis from..

Give credit where it is due

1pm  Plc (LON:OPM)  IFRS9 update highlighted the conservatism in current provisioning, with a minimal impact from adopting the new standard. We have taken the opportunity to review credit and present..

Capital increase for further development

Avacta (LON:AVCT) is a pre-clinical stage biotechnology company and the proprietary owner of Affimer technology. Affimers represent a radical alternative to the established antibody technology, which continues to dominate the..

Quoted companies can adjust to the post-MIFID II world

Quoted Companies Alliance (QCA), an organisation that champions the interests of small to mid-size quoted companies. The QCA is known as an authoritative voice in the capital markets space for..

Redx Pharma Back to the clinic

Redx Pharma Plc (LON:REDX) new management team is continuing to focus its financial resources on progressing its lead candidates in oncology and fibrotic disease into the clinic. When the first..

Elegant Hotels Group PLC Shares off 18% since interims

Zeus Capital note the recent weakness in Elegant Hotels Group PLC (LON:EHG) share price, which is down 18% since the interim results and now at the lowest point since December..

MySale Group plc Shares off 40% since solid July pre-close trading update creates opportunity

Since issuing a reassuring pre-close trading update in July, MySale Group Plc (LON:MYSL) shares have declined 40% resulting in a year-to-date drop of 62%, which looks completely unwarranted in our..

Epwin Group plc Trading in line in FY18 despite the market outlook remaining difficult

Epwin Group plc (LON:EPWN) has released a brief update this morning indicating that trading in the first half of the year has been in line with expectations (Zeus Capital full..

Oxford BioMedica Risk-sharing in cystic fibrosis gene-therapy

Oxford BioMedica (LON:OXB) is a specialist, advanced-therapy, lentivirus vector biopharma company. It offers vector manufacturing and development services and has a proprietary drug pipeline. In addition to LentiVector® service contracts,..

Ceres Power Continued demand for its technology

Ceres Power Holdings Plc (LON:CWR) General Meeting on Friday approved of the recent £20m fundraise and the first tranche of £19.4m of Weichai’s strategic investment, both at 15.08p. In addition,..

Search

Funds

Broker Notes, Comments and Analysis

Search

Funds

Broker Notes, Comments and Analysis

FTSE 100

Funds